Domestic price of Crizotinib

Crizotinib is a tyrosine kinase receptor inhibitor indicated for the treatment of anaplastic lymphoma kinase (ALK) or ROS1-positive non-small cell lung cancer (NSCLC) tumors, as well as ALK-positive anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumor (IMT). The original drug has been launched in China and is included in the scope of medical insurance, but only patients who meet the indications can be reimbursed. The price of each box of 250mg*60 pills may be around 15,000 yuan, and the price of 200mg*60 pills per box may be around 10,000 yuan. The Turkish original version of crizotinib currently sold overseas, with a specification of 250mg*60 capsules, may cost more than 10,000 yuan per box (the price may fluctuate due to exchange rates), which is expensive.